LONG BEACH, CA, March 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced an agreement with Noramco, Inc. (Noramco) for the manufacturing and scale-up of Nemus’ proprietary analog of cannabidiol (CBD) licensed from the University of Mississippi. Noramco is a recognized, global producer and provider of controlled substances, including cannabinoids, to the pharmaceutical industry.
according to the webpage of the U.S. Patent and Trademark Office, Eastside Distilling applied for the trademark on Feb. 26, and on March 1, the Office accepted the application. The trademarked name for Eastside Distilling’s hemp-based beverage is “OUTLANDISH.”
MADISON, Wis. (WSAW) — Nearly 2,100 individuals and businesses have applied to grow or process industrial hemp in 2019, according to a news release from the Department of Agriculture, Trade and Consumer. “This is a dramatic increase from last year,” stated Brian Kuhn, director of the department’s Plant Industry Bureau, which houses the hemp program.